GlassScriptPhysician profile
Anusha Yelisetty
NPI 1568849321
$2,708.59
in general payments reported to CMS, 2019-2025
8 companies · $1,802 in 2025
The $1,802 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.38 · 2022: $92.86 · 2023: $165 · 2024: $637 · 2025: $1,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $659 · Travel and Lodging: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $658.62 |
| Travel and Lodging | $445.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,286.76 | 2023-2025 | Da Vinci Surgical System |
| Pulmonx Corporation | $179.92 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Glaxosmithkline, LLC. | $92.86 | 2022 | |
| Genzyme Corporation | $56.87 | 2024 | |
| Insmed, INC. | $52.81 | 2023 | |
| Ambu INC. | $14.46 | 2024 | |
| Baxter Healthcare | $13.53 | 2023 | Hillrom - Volara System |
| Mylan Specialty L.P. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anusha Yelisetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.